𝐍𝐨𝐫𝐝𝐢𝐜 𝐋𝐢𝐟𝐞 𝐒𝐜𝐢𝐞𝐧𝐜𝐞 𝐏𝐥𝐚𝐭𝐟𝐨𝐫𝐦 - 𝐘𝐨𝐮𝐫 𝐠𝐚𝐭𝐞𝐰𝐚𝐲 𝐭𝐨 𝐂𝐡𝐢𝐧𝐚’𝐬 𝐡𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐦𝐚𝐫𝐤𝐞𝐭
*Market Access  *Regulatory Strategy *China Market Entry

𝐀𝐛𝐨𝐮𝐭
The Nordic Life Science Platform (NLSP), with offices in Copenhagen and Shanghai, is dedicated to effectively bridging the demand for innovative medical products and solutions in China with the supply of Nordic medtech, healthtech, biotech, and pharma companies.

We aim to promote collaboration and communication between both sides, driving innovation and development within health and life science.

China is the world’s second largest healthcare market and one of the fastest-growing life science markets. For innovative life science companies ready to explore and expand beyond their home market, navigating the regulatory framework, IPR protection, market conditions, and local partnerships can feel overwhelming.

NLSP exists to change that. We are a specialized consultancy helping mostly Nordic life science companies enter and grow in China — with the expertise, local depth, and international standards you need to move forward with confidence.

We don't just advise. We go deep into your product, your timeline, and your risk tolerance — and build the pathways that fit.

𝐖𝐡𝐚𝐭 𝐰𝐞 𝐝𝐨
•	Market entry planning & localization
•	Matchmaking & Fast-track product approvals
•	Regulatory strategy & NMPA registration
•	IPR protection & trade secret advisory
•	Partner identification & due diligence

NLSP also assists companies interested in investing in and partnering up with Nordic and Chinese life science companies by identifying potential investment opportunities that complement their product portfolios.

If you are considering China as your next growth market, we would like to hear from you.

Ready to explore? Send us a message to info@nlsp.dk or visit our website.

Nordic Life Science Platform

Org chart

Teams

Offices